Complex Journey from Innovation to Patient impact
Beyond Reporting - Safety surveillance analytics for medical devices...
Elevating Drug Safety
Two Acts, One Geopolitical Moment
Why Sustainable Biomanufacturing Must Start Earlier in The Process
EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Designing and Developing Green Drug Delivery Systems: From natural bioactives to sustainable therapeutics
Associate Professor, Somaiya Institute for Research and Consultancy
Dr Maushmi S Kumar is a Life Sciences Researcher Academician and Translational Drug Discovery Scientist with years of experience across academia and pharmaceutical industry Her research spans drug design marine bioactives chemical biology molecular pharmacology and advanced drug delivery with a strong focus on translating discoveries toward therapeutic development for cancer and neurodegenerative...
Articles
New Paradigm in Combination Therapy of siRNA with Chemotherapeutic Drugs towards Cancer Targeting
Cancer is a dynamic cellular process in which complex interplay of cellular interactions and genetic alterations characterised by multiple gene mutations occur The complexity of signaling pathways makes treatment of cancer difficult due to altered cellular mechanisms which cause cell death This calls for treatment modalities which can target the molecular mechanisms involved in cancer patho phys...
Research Insights
Mapping Metabolic Reprogramming in Lung and Breast Cancer Through Integrative Bioinformatics
Metabolic reprogramming is central to cancer biology enabling tumor cells to sustain rapid proliferation resist stress and adapt to therapy However these alterations are highly heterogeneous across cancer types
Case Studies
Local Production Of Pharmaceuticals And Related Technology Transfer In Developing Countries
Abstract As stakeholders in the Global Strategy and Plan of Action on Public Health Innovation and Intellectual Property GSPAPHI adopted by the World Health Assembly in the United Nations Conference on Trade and Development UNCTAD the World Health Organization WHO and the International Centre for Trade and Sustainable Development ICTSD are col
Techno Trends
Aptar Pharma and Medtech firms to Develop Novel Auto-injector
Aptar Pharma a segment of AptarGroup entered into an exclusive development and license agreement with BD Becton Dickinson and Company a medtech firm to jointly develop a novel autoinjector In developing this injector Aptar Pharma uses its twostep autoinjector technology and prefillable syringes from BD Autoinjectors are designed
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Why Pharma's Safety Net Must Follow the Medicine Home
Barbara works closely with leaders across pharmaceutical, medical devices and solution providers serving healthcare organisations - all of whom are using digital product identities.
Much of her time is spent with product owners and senior leaders in packaging, operations, anti-counterfeit, manufacturing, and with system integrators. She is focused on protecting patient safety at scale, serving leadership with trusted data and improving efficiency through innovative solutions.
Barbara's background spans innovation strategy, partnership development, marketing and commercial roles and cross-functional leadership in highly regulated settings. She is known for her collaborative and pragmatic approach, working alongside teams to explore long-term roadmaps that balance progress with responsibility.
Barbara cares deeply about how healthcare systems evolve without compromising what matters most. She is always open to conversations with leaders who are navigating similar challenges and looking to move forward responsibly.
Futuristic Application of Human-On-A-Chip Technology
Joseph Xavier is currently pursuing his PhD in the Division of Toxicology,SCTIMST, Trivandrum, Kerala. He is currently working on the development of multi-organ-on-a-chip for disease modelling and toxicity assessments. His work also focuses on elucidating the cellular mechanism of toxicity of nanomaterials.
Akhil Venugopal is currently working as a Junior Research Fellow in the Division of Toxicology, SCTIMST, Trivandrum. He obtained his Integrated BS-MS in Chemistry from Indian Institute of Science Education and Research (IISER), Mohali. His research work is focused on the fabrication of multi-organ micro physiological devices for pre-clinical studies.
Arathi Ashok obtained her Masters in Microbiology from Amrita Vishwa Vidyapeetham, Kerala. She is currently working as a Junior Research Fellow in the Division of Toxicology, SCTIMST, Trivandrum. Her research work lies in the development of organ-on-a chip devices for toxicity assessment.
PV. Mohanan, FNASc, FRSB, Scientist-G and Head of Division of Toxicology and Associate Dean (PhD program) in Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Govt. of India. He has more than 33 years of research experience in Toxicology. He is a Certified Biological Safety Specialist and has authored 233 publications and edited 6 books. He is also a Visiting Professor and Visiting Researcher at Toyo University, Japan.
Tobacco-style Label Warning on Alcohol Products
Dr. M. Aamir Mirza is working as an Assistant Professor in the Department of Pharmaceutics, Jamia Hamdard, an NIRF Rank 1 institute and a NAAC ‘A+” grade deemed to be University. He has a multifaceted career portfolio adorned with both industry
Nanotechnology based Drug Delivery for Infectious Diseases
Dr. Vinod Kumar Rajana, Assistant Professor of Pharmaceutics, specializes in nanotechnology, bioassays, and infectious disease research. With expertise in nanoparticle synthesis, biotechnology, and drug delivery, his work integrates green chemistry with pharmaceutical innovation to develop sustainable, low-cost nanomaterials for topical antifungal and anticancer therapies, water purification, and biomedical applications.
APAC’s Biopharma Providers’ Role in Pioneering a Healthcare Revolution
Narayana is responsible for leading the overall business, P&L, strategy, and program management for Avantor’s Biopharma Business Unit in AMEA. He possesses close to two decades of comprehensive experience in international markets, leading diverse teams in account, product, sales and business management, and delivering strategic solutions for Consumables, systems and Instruments in Academic, Pharmaceuticals, Bioprocessing, and Bioresearch Industries.
press releasesRead more...
Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.
Telix and Ekalia a joint venture between IBA Ion Beam Applications SA EURONEXT and Framatome today announced a collaboration to advance scalable United States US production of astatine At an alphaemitting radioisotope being investigated for targeted alpha therapy
HistoIndex and A*STAR Partner To Advance Early – Stage Development Of Pipeline Therapies For Fibrotic Diseases
HistoIndex a pioneer in AIdriven digital pathology for fibrotic diseases and the Agency for Science Technology and Research ASTAR Singapores lead public sector RD agency have signed a Memorandum of Understanding MoU to collaborate on the preclinical evaluation
Cotecna Group Acquires Energon Labs
Cotecna a leading provider of Testing Inspection and Certification TIC services today announced the acquisition of Energon Labs a cGMPcompliant USFDAinspected ISO and ISO certified analytical testing laboratory based in Hyderabad India
Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release
Waters Corporation announced that it has launched Waters AI Link a software capability that brings Anthropics Model Context Protocol MCP to its informatics platform and has joined Anthropics Model Hardware Standard MHS research program
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1
Takeda announced that ORZEYFUL oveporexton is now available in Japan and China for the treatment of narcolepsy type NT providing first access to clinicians to prescribe treatment with the new class of medicine ORZEYFUL is a firstinclass orexin receptor OXR agonist in tablet form designed to treat...
Merck Inaugurates State-of-the-Art ADVANCE Bioanalytical Facility on West Point, Pennsylvania, Campus
Merck known as MSD outside of the United States and Canada today inaugurated its stateoftheart ADVANCE research facility on its West Point Pennsylvania campus signaling a new chapter in global scientific discovery Pennsylvania Gov Josh Shapiro joined Merck executive leadership federal and state gove...
EventsRead more...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
27 - 28
Oct 2026PM& AC 2026
Novotel Hyderabad Convention C...
28 - 30
Oct 2026BIOPLUS-INTERPHEX KOREA 2026
COEX, Seoul
02 - 04
Nov 2026Pharma Forum EMEA 2026
Dom Pedro Lisboa Hotel, Lisbon...
LATEST NEWSRead more...
UCB Receives Approval for ZILBRYSQ Autoinjector for Adults with Generalised Myasthenia Gravis
UCB has received approval from the US Food and Drug Administration FDA for a new autoinjector option for ZILBRYSQ zilucoplan a treatment for adults with generalised myasthenia gravis gMG who test positive for antiacetylcholine receptor AChR antibodies
Nxera Pharma Partners with Synmosa to Commercialise QUVIVIQ
Nxera Pharma has entered into an exclusive licensing supply and commercialisation agreement with Synmosa Biopharma to expand access to QUVIVIQ daridorexant a medicine used to treat insomnia across eight AsiaPacific markets QUVIVIQ was discovered and developed by Idorsia Pharmaceuticals
Vir Biotechnology Enters into Collaboration with Gilead Sciences to Develop T-cell Engagers for Solid Tumours
Vir Biotechnology has entered into a collaboration and licensing agreement with Gilead Sciences to discover and develop three novel Tcell engager TCE candidates for the treatment of solid tumours Tcell engagers are designed to direct T cells a type of immune cell towards cancer cells and help destro...
Zealand Pharma Enters into Collaboration with Generate Biomedicines on AI-Designed Protein Therapies for Metabolic Diseases
Zealand Pharma and Generate Biomedicines have entered into a multitarget collaboration and licensing agreement to develop proteinbased treatments for obesity and other metabolic diseases using artificial intelligence AI The collaboration will combine Zealand Pharmas expertise in metabolic diseases w...
Enodia Therapeutics Enters into Collaboration with Pfizer to Develop Small-Molecule Sec61 Inhibitors
Enodia Therapeutics has entered into a research collaboration and licensing agreement with Pfizer to discover and develop smallmolecule inhibitors targeting Sec a protein complex involved in the movement of newly formed proteins across cell membranes
InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China
InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases announced today that the Center for Drug Evaluation CDE of Chinas National Medical Products Administration NMPA has approved its Investigational New Drug IND application for ICPB a bispeci...
